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CASE DESCRIPTION 
 
A 43-year-old female with prior history of 
intractable postoperative nausea and 
vomiting (PONV) under general anesthesia 
(GA) presented for open reduction and 
internal fixation of left patella for a malunion 
fracture.  An ultrasound-guided femoral 
nerve block was placed prior to GA with 
25cc of 0.25% bupivacaine. GA with LMA 
was maintained under total intravenous 
anesthesia with propofol, midazolam and 
fentanyl. Her PONV prophylaxis included 
scopolamine dermal patch, intravenous (IV) 
dexamethasone, and ondansetron. She was 
hydrated with two (2) liters of LR. She did 
not have PONV for the first time in her 
anesthetic history. 
 
CASE DISCUSSION 
Mechanism of Nausea and Vomiting 
 
 
The chemoreceptor trigger zone (CRTZ), located at the 
caudal end of the fourth ventricle in the area prostrema, and 
the nucleus tractus solitaries (NTS), are centrally-located 
structures in the brain responsible for nausea  and vomiting.   
The CTRZ receives input from the GI tract via vagal 
afferents.  It can also detect emetogenic toxins from blood 
and CSF. It lacks blood brain barrier. The CRTZ projects 
neurons to the NTS, which receives input from vagal 
afferents and the limbic system. NTS triggers vomiting by 
stimulating the rostral nucleus, the nucleus ambiguous, the 
ventral respiratory group, and the dorsal motor nucleus of the 
vagus.1 
 
 
 
CONCLUSION 
 
 
Patients with PONV often exhibit nausea, gagging and vomiting 
for the first two days post-surgery. Since PONV is a high 
contributor to patient dissatisfaction, it is highly important to 
take preventive measures against it.  While it may be difficult to 
eliminate PONV, it is essential to reduce it. 
  
Female patients are more susceptible to experiencing PONV 
compared to male patients.4 Additionally, patients who are 
younger, abstain from smoking, and have a past history of 
motion sickness are more subject to suffer from PONV.4  
Preoperative opioid use, nitrous oxide, and volatile anesthesia 
can significantly increase the risk of PONV, as can certain 
surgical procedures, including laparoscopic, gynecological and 
abdominal surgery.  
  
Hydrating the patient5,6, limiting nitrous oxide and volatile 
anesthetic use, and using propofol for induction and 
maintenance, can prevent PONV. Studies have shown that high 
IV fluids therapy (30mL/kg) is associated with less emesis, 
however there is no significant difference between crystalloid 
vs. colloid fluids.5 Additionally, regional rather than general 
anesthesia can significantly reduce PONV. Therapies combining 
antiemetic prophylaxis with multimodal strategies for non-
opioid postoperative pain control, such as regional anesthesia, 
acetaminophen, and NSAIDs, may reduce the risk of PONV. 
Acupressure wristbands used before emetic stimulus exposure 
(i.e. anesthetic agents) for short surgeries have also proved a 
beneficial preventative measure.6 
REFERENCES 
 
1. Continuing Education in Anaesthesia, Critical Care & Pain 2013; 13.  
2.  Apfel CC, et al. Volatile anaesthetics may be the main cause of early but not delayed 
postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. 
2002;88:659-68. 
3. Wallenborn J, et al.  The impact of isoflurane, desflurane, or sevoflurane on the 
frequency and severity of postoperative nausea and vomiting during lumbar disc 
surgery. J Clin Anesth. 2007; 19:180-5. 
4. . Apfel CC, et al. Evidence-based analysis of risk factors for postoperative nausea 
and vomiting. Br J Anaesth 109 (5); 742 – 753. 2012. 
5. Gan TJ, et al. Consensus guidelines for the management of postoperative nausea 
and vomiting. Anesth Analg 118 (1): 85 – 113. 2014. 
6. Feinleib J, et al. Postoperative nausea and vomiting.  UpToDate. September 8, 2017. 
 
Risk Factors for PONV1    
 
 
 
 
 
  
 
 
 
 
 
 
 
The use of the volatile anesthetic agent is a main risk factor for 
PONV.  Incidence of PONV depends on duration and the 
concentration of volatile anesthetic agent used.2  There is no 
difference in incidence between sevoflurane, desflurane and 
isoflurane. 2,3  
Pharmacological Antiemetic 
Prophylaxis 
 
 Serotonin antagonists (5 HT3): Ondansetron 
 Corticosteroids: Dexamethasone 
 Anticholinergic agents: Transdermal 
scopolamine 
 Dopaminergic antagonists (D2): Haloperidol, 
Metoclopramide 
 Antihistaminic agents: Diphenhydramine  
 Neurokinin 1 receptor antagonists: 
Aprepitant, Rolapitant 
Patient-related: Female gender; children; past 
history of PONV; motion sickness; 
nonsmoking status 
Surgery-related: Eye surgery (Strabismus surgery); 
ENT surgery; gynecological 
surgery; thyroid surgery; surgery 
duration 
>1 hour 
Anesthesia-related: Volatile anesthetic agents; opiates; 
nitrous oxide 
Figure 16: Postoperative nausea and vomiting may occur via multiple 
peripheral and central mechanisms, mediated by a variety of 
neurotransmitters and receptors. 
NTS: nucleus tractus solitarius; AP: area postrema; CPG: central pattern 
generator; NK1: neurokinin 1; 5 HT3:5-hydroxytryptamine (serotonin); GI: 
gastrointestinal; CNS: central nervous system. [Feinleib, et al. UpToDate, 
Copyright 2017.] 
 
